Alfonso E Bello is categorized under Internal Medicine Doctors in Morton Grove, IL and active since 2010.
Alfonso E Bello was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Alfonso E Bello at the company’s single location by writing to 9000 Waukegan Road # 200, Morton Grove, Illinois IL 60053 or by phoning (847) 375-3000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Alfonso E Bello |
| Contact Person: | Alfonso E Bello |
| Address: | 9000 Waukegan Road # 200, Morton Grove, Illinois 60053 |
| Phone Number: | (847) 375-3000 |
| Website Address: | ibji.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Alfonso E Bello was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Alfonso E Bello for inquiries that concern Alfonso E Bello by calling the company number (847) 375-3000, as your correspondence is most welcome. Additionally, the physical location of the single location of Alfonso E Bello can be found at the coordinates 42.0449,-87.799392 as well as the street address 9000 Waukegan Road # 200 in Morton Grove, Illinois 60053.
For its online presence, you may visit Alfonso E Bello’s website at ibji.com and engage with its social media outlets through on Twitter and on Facebook.